PR News

Nazi In the News: NY Jewish Film Festival

Editorial TeamBy Editorial Team1 min read
Nazi In the News: NY Jewish Film Festival
Share

Otto Adolf EichmannA new documentary entitled "The Trial of Adolf Eichman" is now available worldwide, after its USA Premier at the New York Jewish Film Festival. And as an interesting corollary news bit, a former SS officer stands trial this week for alleged WW II crimes. The 1961 trial of Adolf Eichmann held in an Israeli courtroom and broadcast around the globe, was a benchmark event in the historiography of the Holocaust, especially in Israel where the trial proved a watershed experience for survivors and citizens of the new Jewish state. Employing new video and broadcast technologies, the trial was also a milestone in media and journalism coverage. From the producers of Being Jewish in France this absorbing, comprehensive new documentary features detailed accounts of Eichmann's capture, the drama in the courtroom and behind the scenes, and reactions to the trial from around the world.
"Quite simply, this movie is one which is remarkable and has amazing footage which remain historically significant today.  The words "Never Again" only will truly be accurate if people learn from history, and this movie will enable them to ensure they learn and remember," said award winning film maker Mark Birnbaum.
Ironically, news of a former Nazi SS officer facing a murder trial over the death of a WW II Dutch Resistance fighter was release just today. in the death of a Dutch Resistance fighter nearly 70 years ago during World War II. BBC reported 92 year old Siert Bruins, a Dutch-born German, set for trial in Hagan, Germany for allegedly killing POW Aldert Klaas Dijkema in September 1944. The trial, certain to be one of the last of its kind in Germany, could see the former SS officer living out his life in prison. Bruins claims he was there, but marching beside the prisoner when the 4 shots struck the victim in the back.
Editorial Team
Written by
Editorial Team

The Everything-PR Editorial Team produces reporting, research, and analysis across thirty verticals — communications, reputation, AI visibility, public affairs, media systems, and digital discovery in the answer-engine era. Publishing since 2009.

Other news

See all
 Why the Best Digital Marketing in 2026 Feels Human Again
Editorial Team · 05/25/2026

Why the Best Digital Marketing in 2026 Feels Human Again

For the better part of the last decade, digital marketing has been defined by one word: efficiency. Marketers optimized everything. Audiences were segmented into increasingly granular cohorts. Creative was tested, iterated, and refined at scale. Entire strategies were built around performance dashboards—click-through rates, conversion rates, cost per acquisition. It was a golden age of precision. And yet, something got lost along the way. Scroll through any social platform today and you’ll encounter a paradox: marketing has never been more targeted, yet it has never felt more invisible. Ads are technically excellent, but emotionally vacant. Campaigns perform, but they rarely linger. Brands reach people, but they struggle to move them. This is the defining tension of digital marketing in 2026.

The SAFE Banking Communications Playbook (Updated Q2 2026)
Editorial Team · 05/25/2026

The SAFE Banking Communications Playbook (Updated Q2 2026)

SAFE Banking has been "almost passing" for seven years. The communications stakes just got higher. Schedule III rescheduling raised institutional investor interest. The operators that build the right banking narrative now win citation share — whether SAFER passes or doesn't.

280E Repeal Communications: What MSOs Should Be Saying Right Now
Editorial Team · 05/25/2026

280E Repeal Communications: What MSOs Should Be Saying Right Now

280E has crushed cannabis P&Ls for fifteen years. The April 23 Schedule III order ended it — for some operators. The MSOs that communicate the partial repeal with discipline win the post-rescheduling citation graph. The rest don't.

Never Miss a Headline

Daily PR headlines, weekly long-form analysis, and our proprietary research drops — straight to your inbox.